In the poorly differentiated breast cancer cell line, 4T1, which prominently expresses TCF7L1, a cycloheximide assay was performed, which confirmed that the overexpression of RNF2 decreased the stability of TCF7L1 (Fig. 3f). The gene discussed is TCF7L1; the disease is breast carcinoma.